3.28
0.15 (4.79%)
Previous Close | 3.13 |
Open | 3.00 |
Volume | 14,984 |
Avg. Volume (3M) | 31,304 |
Market Cap | 35,314,448 |
Price / Sales | 0.490 |
Price / Book | 0.460 |
52 Weeks Range | |
Earnings Date | 26 May 2025 - 30 May 2025 |
Profit Margin | -45.59% |
Operating Margin (TTM) | -11.41% |
Diluted EPS (TTM) | -3.22 |
Quarterly Revenue Growth (YOY) | 5.90% |
Total Debt/Equity (MRQ) | 7.40% |
Current Ratio (MRQ) | 3.02 |
Operating Cash Flow (TTM) | -75.58 M |
Levered Free Cash Flow (TTM) | -7.97 M |
Return on Assets (TTM) | -14.39% |
Return on Equity (TTM) | -37.03% |
Market Trend
Short Term | Medium Term | ||
Industry | Diagnostics & Research (US) | Mixed | Mixed |
Diagnostics & Research (Global) | Mixed | Mixed | |
Stock | Burning Rock Biotech Limited | Mixed | Mixed |
AIStockmoo Score
Analyst Consensus | NA |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 3.5 |
Technical Oscillators | 0.5 |
Average | 0.67 |
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others. |
|
Sector | Healthcare |
Industry | Diagnostics & Research |
% Held by Insiders | 3.92% |
% Held by Institutions | 59.86% |
Ownership
Name | Date | Shares Held |
---|---|---|
Crcm Lp | 31 Dec 2024 | 325,969 |
Shen Neil Nanpeng | 31 Dec 2024 | 885 |
No data within this time range.
No data within this time range.
Date | Type | Details |
---|---|---|
06 Jun 2025 | Announcement | Burning Rock Reports First Quarter 2025 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |